

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-proline hydroxylation (GO:0019511) | 6.96020905 |
| 2 | 4-hydroxyproline metabolic process (GO:0019471) | 6.75869689 |
| 3 | protein hydroxylation (GO:0018126) | 5.90491197 |
| 4 | glucose 6-phosphate metabolic process (GO:0051156) | 5.51228951 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.39339413 |
| 6 | protein retention in ER lumen (GO:0006621) | 5.34150147 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.87688886 |
| 8 | protein carboxylation (GO:0018214) | 4.87688886 |
| 9 | glycolytic process (GO:0006096) | 4.61746646 |
| 10 | phosphate ion transmembrane transport (GO:0035435) | 4.48268974 |
| 11 | regulation of complement activation (GO:0030449) | 4.39155593 |
| 12 | desmosome organization (GO:0002934) | 4.33044632 |
| 13 | regulation of protein activation cascade (GO:2000257) | 4.32809769 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 4.26912154 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 4.26912154 |
| 16 | regulation of cholesterol homeostasis (GO:2000188) | 4.12506438 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.03002360 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 4.00006147 |
| 19 | proline biosynthetic process (GO:0006561) | 3.97590266 |
| 20 | negative regulation of lipase activity (GO:0060192) | 3.87212426 |
| 21 | basement membrane organization (GO:0071711) | 3.87025626 |
| 22 | proline metabolic process (GO:0006560) | 3.84330415 |
| 23 | plasma lipoprotein particle assembly (GO:0034377) | 3.81237945 |
| 24 | skin morphogenesis (GO:0043589) | 3.79510713 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 3.78813786 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.77400584 |
| 27 | phosphate ion transport (GO:0006817) | 3.65924445 |
| 28 | pinocytosis (GO:0006907) | 3.65886094 |
| 29 | regulation of apoptotic cell clearance (GO:2000425) | 3.65166292 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62496817 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.62496817 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 3.59817683 |
| 33 | gluconeogenesis (GO:0006094) | 3.51648011 |
| 34 | positive regulation of extracellular matrix organization (GO:1903055) | 3.50650777 |
| 35 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.50077171 |
| 36 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.46336032 |
| 37 | hexose biosynthetic process (GO:0019319) | 3.45680280 |
| 38 | regulation of plasminogen activation (GO:0010755) | 3.43518065 |
| 39 | protein-lipid complex assembly (GO:0065005) | 3.43270641 |
| 40 | lung epithelium development (GO:0060428) | 3.37573702 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 3.35942340 |
| 42 | urate metabolic process (GO:0046415) | 3.31872950 |
| 43 | drug transmembrane transport (GO:0006855) | 3.30172891 |
| 44 | lung vasculature development (GO:0060426) | 3.28257915 |
| 45 | endothelial cell morphogenesis (GO:0001886) | 3.23568289 |
| 46 | pyruvate metabolic process (GO:0006090) | 3.21528886 |
| 47 | regulation of bile acid biosynthetic process (GO:0070857) | 3.21171868 |
| 48 | cholesterol efflux (GO:0033344) | 3.17665916 |
| 49 | monosaccharide biosynthetic process (GO:0046364) | 3.16542903 |
| 50 | fructose metabolic process (GO:0006000) | 3.15024102 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 3.06174455 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.05033127 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.02372157 |
| 54 | L-phenylalanine catabolic process (GO:0006559) | 3.02372157 |
| 55 | regulation of extracellular matrix organization (GO:1903053) | 3.01891227 |
| 56 | artery smooth muscle contraction (GO:0014824) | 3.00774307 |
| 57 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.00153944 |
| 58 | regulation of metalloenzyme activity (GO:0048552) | 2.99531113 |
| 59 | hemidesmosome assembly (GO:0031581) | 2.99457343 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 2.97588315 |
| 61 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.96647269 |
| 62 | regulation of extracellular matrix disassembly (GO:0010715) | 2.95283695 |
| 63 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.95125321 |
| 64 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.93949909 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93904048 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 2.93904048 |
| 67 | macromolecular complex remodeling (GO:0034367) | 2.93904048 |
| 68 | cell adhesion mediated by integrin (GO:0033627) | 2.90167674 |
| 69 | surfactant homeostasis (GO:0043129) | 2.88710278 |
| 70 | regulation of cholesterol metabolic process (GO:0090181) | 2.86079937 |
| 71 | positive regulation of nuclease activity (GO:0032075) | 2.85972871 |
| 72 | COPII vesicle coating (GO:0048208) | 2.85593358 |
| 73 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.84113417 |
| 74 | regulation of fibrinolysis (GO:0051917) | 2.83968526 |
| 75 | type B pancreatic cell proliferation (GO:0044342) | 2.82402221 |
| 76 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.81737910 |
| 77 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.80253492 |
| 78 | fibrinolysis (GO:0042730) | 2.77797665 |
| 79 | plasma lipoprotein particle organization (GO:0071827) | 2.77436959 |
| 80 | nephron tubule formation (GO:0072079) | 2.67589893 |
| 81 | positive regulation of hormone metabolic process (GO:0032352) | 2.67059912 |
| 82 | complement activation, alternative pathway (GO:0006957) | 2.67008081 |
| 83 | negative regulation of complement activation (GO:0045916) | 2.65500540 |
| 84 | tonic smooth muscle contraction (GO:0014820) | 2.64638751 |
| 85 | intestinal absorption (GO:0050892) | 2.64443684 |
| 86 | negative regulation of metanephros development (GO:0072217) | 2.64441495 |
| 87 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.64413943 |
| 88 | reverse cholesterol transport (GO:0043691) | 2.63192397 |
| 89 | progesterone metabolic process (GO:0042448) | 2.63120143 |
| 90 | protein-lipid complex subunit organization (GO:0071825) | 2.63018489 |
| 91 | low-density lipoprotein particle clearance (GO:0034383) | 2.62906390 |
| 92 | endothelial cell chemotaxis (GO:0035767) | 2.60517396 |
| 93 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.60248133 |
| 94 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.59775444 |
| 95 | myelin maintenance (GO:0043217) | 2.59771434 |
| 96 | nephron tubule morphogenesis (GO:0072078) | 2.58940685 |
| 97 | nephron epithelium morphogenesis (GO:0072088) | 2.58940685 |
| 98 | regulation of mesonephros development (GO:0061217) | 2.58176126 |
| 99 | glomerular visceral epithelial cell development (GO:0072015) | 2.56031998 |
| 100 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.54903439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.60526675 |
| 2 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 5.53259073 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.09492131 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.87774409 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.40319962 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.26612081 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18039808 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.94411824 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.55431297 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34137475 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33136534 |
| 12 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.27813331 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.21581978 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17999354 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17938721 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.10139512 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05674265 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04309828 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90792568 |
| 20 | ATF3_27146783_Chip-Seq_COLON_Human | 1.87203480 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.87173697 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82306004 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79018639 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.72205444 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71151095 |
| 26 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.64466615 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59499998 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56246943 |
| 29 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54945589 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54874653 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51979249 |
| 32 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.50571359 |
| 33 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.49401791 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47069705 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46974288 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42041278 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40664437 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39464039 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38790105 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38065264 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36397489 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36277510 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35132262 |
| 44 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.34272307 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33685239 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33399483 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33399483 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30695738 |
| 49 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.30388491 |
| 50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27685206 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27413268 |
| 52 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23577283 |
| 53 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22386490 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22075345 |
| 55 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21840825 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21648468 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21431359 |
| 58 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21231984 |
| 59 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19738244 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19397474 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19208867 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19071011 |
| 63 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18624452 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16344912 |
| 65 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.15749414 |
| 66 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.15513605 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14976593 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14716519 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12696806 |
| 70 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.12173356 |
| 71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11699685 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11546909 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11434052 |
| 74 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11309349 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09840141 |
| 76 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09225083 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09027240 |
| 78 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08481913 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08418828 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06977458 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04573380 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04143024 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03790114 |
| 84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02080610 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01670380 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01504297 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00434675 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00002054 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99548520 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99172392 |
| 91 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.99044243 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97106662 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96985099 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95772473 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95218681 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94998038 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94977606 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93006814 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92072086 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91258842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.71804259 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.22034272 |
| 3 | MP0005360_urolithiasis | 3.73002059 |
| 4 | MP0004272_abnormal_basement_membrane | 3.63192234 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.94502250 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.84455253 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.73715037 |
| 8 | MP0003123_paternal_imprinting | 2.71762144 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.39884351 |
| 10 | MP0000566_synostosis | 2.34544880 |
| 11 | MP0005365_abnormal_bile_salt | 2.17044240 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.09733754 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.05504326 |
| 14 | MP0005451_abnormal_body_composition | 2.04153032 |
| 15 | MP0003122_maternal_imprinting | 2.03669579 |
| 16 | MP0002060_abnormal_skin_morphology | 1.96502334 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.93455697 |
| 18 | MP0005409_darkened_coat_color | 1.92343544 |
| 19 | MP0009840_abnormal_foam_cell | 1.84255520 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.82801199 |
| 21 | MP0005023_abnormal_wound_healing | 1.82402549 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.81808368 |
| 23 | MP0000762_abnormal_tongue_morphology | 1.72098077 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.71590753 |
| 25 | MP0003315_abnormal_perineum_morphology | 1.70000211 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.69682073 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.67625848 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.64256694 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.62714681 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.62462223 |
| 31 | MP0002796_impaired_skin_barrier | 1.61957594 |
| 32 | MP0005083_abnormal_biliary_tract | 1.60377548 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.58538479 |
| 34 | MP0004233_abnormal_muscle_weight | 1.54175228 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52201604 |
| 36 | MP0008260_abnormal_autophagy | 1.40593807 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.39747928 |
| 38 | MP0005275_abnormal_skin_tensile | 1.36298151 |
| 39 | MP0005408_hypopigmentation | 1.34684147 |
| 40 | MP0001915_intracranial_hemorrhage | 1.34303184 |
| 41 | MP0000579_abnormal_nail_morphology | 1.33693958 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.30792647 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.27106228 |
| 44 | MP0001849_ear_inflammation | 1.26891683 |
| 45 | MP0003195_calcinosis | 1.26124970 |
| 46 | MP0005501_abnormal_skin_physiology | 1.24930513 |
| 47 | MP0000467_abnormal_esophagus_morphology | 1.23658695 |
| 48 | MP0005332_abnormal_amino_acid | 1.21965003 |
| 49 | MP0003942_abnormal_urinary_system | 1.18129582 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.16130314 |
| 51 | MP0003879_abnormal_hair_cell | 1.06848123 |
| 52 | MP0005085_abnormal_gallbladder_physiolo | 1.06824480 |
| 53 | MP0003011_delayed_dark_adaptation | 1.06540389 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.05232372 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.04653560 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.03521326 |
| 57 | MP0009053_abnormal_anal_canal | 1.02059144 |
| 58 | MP0010771_integument_phenotype | 0.98532825 |
| 59 | MP0005330_cardiomyopathy | 0.98245656 |
| 60 | MP0001661_extended_life_span | 0.95726377 |
| 61 | MP0001348_abnormal_lacrimal_gland | 0.95099562 |
| 62 | MP0000751_myopathy | 0.94692926 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.92628271 |
| 64 | MP0000609_abnormal_liver_physiology | 0.89922688 |
| 65 | MP0003878_abnormal_ear_physiology | 0.89826575 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 0.89826575 |
| 67 | MP0003115_abnormal_respiratory_system | 0.89397688 |
| 68 | MP0004858_abnormal_nervous_system | 0.88552176 |
| 69 | MP0005410_abnormal_fertilization | 0.87982291 |
| 70 | MP0001756_abnormal_urination | 0.87322643 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87029227 |
| 72 | MP0000537_abnormal_urethra_morphology | 0.86104220 |
| 73 | MP0005670_abnormal_white_adipose | 0.85261092 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.81969356 |
| 75 | MP0010030_abnormal_orbit_morphology | 0.81460169 |
| 76 | MP0000858_altered_metastatic_potential | 0.80982388 |
| 77 | MP0003091_abnormal_cell_migration | 0.80163050 |
| 78 | MP0010678_abnormal_skin_adnexa | 0.80030337 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.79242942 |
| 80 | MP0000747_muscle_weakness | 0.79118518 |
| 81 | MP0003252_abnormal_bile_duct | 0.78612485 |
| 82 | MP0002269_muscular_atrophy | 0.77074044 |
| 83 | MP0005171_absent_coat_pigmentation | 0.75670356 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 0.75304882 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.75156528 |
| 86 | MP0003385_abnormal_body_wall | 0.74661904 |
| 87 | MP0005197_abnormal_uvea_morphology | 0.74112420 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.73911724 |
| 89 | MP0009931_abnormal_skin_appearance | 0.71519021 |
| 90 | MP0006138_congestive_heart_failure | 0.71111364 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.69979096 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.69486255 |
| 93 | MP0002132_abnormal_respiratory_system | 0.66687994 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.66094171 |
| 95 | MP0005503_abnormal_tendon_morphology | 0.62349470 |
| 96 | MP0010630_abnormal_cardiac_muscle | 0.60876742 |
| 97 | MP0003941_abnormal_skin_development | 0.60122246 |
| 98 | MP0005165_increased_susceptibility_to | 0.59820498 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.59504852 |
| 100 | MP0002933_joint_inflammation | 0.59270592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal gallbladder physiology (HP:0012438) | 5.45196671 |
| 2 | Cholecystitis (HP:0001082) | 5.45196671 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.83430767 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.05156674 |
| 5 | Abnormality of glycolysis (HP:0004366) | 3.86931021 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.72428365 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.54496651 |
| 8 | Axonal loss (HP:0003447) | 3.36771284 |
| 9 | Nuclear cataract (HP:0100018) | 3.23126813 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20687711 |
| 11 | Hemorrhage of the eye (HP:0011885) | 3.17919921 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.11925494 |
| 13 | Small epiphyses (HP:0010585) | 3.10047782 |
| 14 | Gout (HP:0001997) | 3.09417680 |
| 15 | Hypercholesterolemia (HP:0003124) | 3.08891361 |
| 16 | Complement deficiency (HP:0004431) | 2.94260306 |
| 17 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.90126460 |
| 18 | Pterygium (HP:0001059) | 2.89760809 |
| 19 | Abnormality of carpal bone ossification (HP:0006257) | 2.81969114 |
| 20 | Focal segmental glomerulosclerosis (HP:0000097) | 2.81479909 |
| 21 | Upper limb amyotrophy (HP:0009129) | 2.72768878 |
| 22 | Distal upper limb amyotrophy (HP:0007149) | 2.72768878 |
| 23 | Increased serum pyruvate (HP:0003542) | 2.70867103 |
| 24 | Abnormality of complement system (HP:0005339) | 2.70458950 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.68813494 |
| 26 | Glomerulosclerosis (HP:0000096) | 2.66076978 |
| 27 | Cerebral aneurysm (HP:0004944) | 2.65778388 |
| 28 | Joint hemorrhage (HP:0005261) | 2.64080574 |
| 29 | Vascular calcification (HP:0004934) | 2.63682541 |
| 30 | Xanthomatosis (HP:0000991) | 2.63433557 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.63410987 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 2.56486015 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55429104 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 2.51941733 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48535687 |
| 36 | Cholelithiasis (HP:0001081) | 2.46255705 |
| 37 | Glucose intolerance (HP:0000833) | 2.42482797 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.42468730 |
| 39 | Flat acetabular roof (HP:0003180) | 2.41757097 |
| 40 | Abnormality of the Achilles tendon (HP:0005109) | 2.41602087 |
| 41 | Reticulocytosis (HP:0001923) | 2.35913812 |
| 42 | Alopecia of scalp (HP:0002293) | 2.35345242 |
| 43 | Neonatal death (HP:0003811) | 2.34327003 |
| 44 | Mitral stenosis (HP:0001718) | 2.33912436 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.31286457 |
| 46 | Broad palm (HP:0001169) | 2.27853449 |
| 47 | Asymmetry of the thorax (HP:0001555) | 2.27425616 |
| 48 | Hypolipoproteinemia (HP:0010981) | 2.24171187 |
| 49 | Wormian bones (HP:0002645) | 2.22672680 |
| 50 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.20865010 |
| 51 | Absent epiphyses (HP:0010577) | 2.20865010 |
| 52 | Abnormal tarsal ossification (HP:0008369) | 2.20549847 |
| 53 | Glomerulonephritis (HP:0000099) | 2.19909042 |
| 54 | Abnormal ossification of hand bones (HP:0005921) | 2.17500675 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.16345645 |
| 56 | Abnormality of the acetabulum (HP:0003170) | 2.12652401 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.11795631 |
| 58 | Cervical subluxation (HP:0003308) | 2.07897226 |
| 59 | Abnormality of the nasal septum (HP:0000419) | 2.07790380 |
| 60 | Abnormality of nail color (HP:0100643) | 2.07758147 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.06355001 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.06355001 |
| 63 | Zonular cataract (HP:0010920) | 2.03118923 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 2.01536161 |
| 65 | Abnormality of dentin (HP:0010299) | 1.99769509 |
| 66 | Achilles tendon contracture (HP:0001771) | 1.99325396 |
| 67 | Abnormal hand bone ossification (HP:0010660) | 1.97483209 |
| 68 | Back pain (HP:0003418) | 1.96870495 |
| 69 | Elbow flexion contracture (HP:0002987) | 1.96860706 |
| 70 | Popliteal pterygium (HP:0009756) | 1.96026934 |
| 71 | Abnormal delivery (HP:0001787) | 1.94001289 |
| 72 | Trismus (HP:0000211) | 1.92289417 |
| 73 | Arterial tortuosity (HP:0005116) | 1.90226719 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 1.87237314 |
| 75 | Shallow orbits (HP:0000586) | 1.86060185 |
| 76 | Renal duplication (HP:0000075) | 1.85451286 |
| 77 | Broad alveolar ridges (HP:0000187) | 1.84580737 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 1.83551169 |
| 79 | Advanced eruption of teeth (HP:0006288) | 1.80047935 |
| 80 | Bifid uvula (HP:0000193) | 1.77172358 |
| 81 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76772404 |
| 82 | Menorrhagia (HP:0000132) | 1.72461563 |
| 83 | Blue sclerae (HP:0000592) | 1.72203498 |
| 84 | Ileus (HP:0002595) | 1.71925510 |
| 85 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71886368 |
| 86 | Overlapping toe (HP:0001845) | 1.71496840 |
| 87 | Broad face (HP:0000283) | 1.71156621 |
| 88 | Mucopolysacchariduria (HP:0008155) | 1.69715639 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69715639 |
| 90 | Premature skin wrinkling (HP:0100678) | 1.66957390 |
| 91 | Coxa vara (HP:0002812) | 1.64174119 |
| 92 | Purpura (HP:0000979) | 1.63899534 |
| 93 | Abnormality of reticulocytes (HP:0004312) | 1.62889676 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 1.62689620 |
| 95 | Plantar hyperkeratosis (HP:0007556) | 1.62532324 |
| 96 | Rhabdomyolysis (HP:0003201) | 1.61555121 |
| 97 | Myopathic facies (HP:0002058) | 1.60465169 |
| 98 | Ulnar bowing (HP:0003031) | 1.59449162 |
| 99 | Atrophic scars (HP:0001075) | 1.58559649 |
| 100 | Palmoplantar hyperkeratosis (HP:0000972) | 1.58338181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.47543085 |
| 2 | EPHA2 | 4.10967164 |
| 3 | FGFR4 | 3.44824131 |
| 4 | WNK4 | 2.67221976 |
| 5 | MET | 2.56783662 |
| 6 | ARAF | 2.54442559 |
| 7 | ICK | 2.53874837 |
| 8 | ERN1 | 2.42182037 |
| 9 | PKN2 | 2.37272585 |
| 10 | IRAK3 | 2.26082435 |
| 11 | MAP3K2 | 2.12795570 |
| 12 | LMTK2 | 2.08632069 |
| 13 | NME2 | 1.99992811 |
| 14 | PTK2 | 1.87597752 |
| 15 | SIK1 | 1.83436906 |
| 16 | PDGFRA | 1.76729779 |
| 17 | EIF2AK1 | 1.75449613 |
| 18 | MAP3K3 | 1.74215692 |
| 19 | MAP3K9 | 1.72442113 |
| 20 | TRIB3 | 1.71639020 |
| 21 | FGFR3 | 1.71614317 |
| 22 | FLT3 | 1.68591402 |
| 23 | NEK1 | 1.63446717 |
| 24 | EEF2K | 1.62930660 |
| 25 | RIPK1 | 1.57621216 |
| 26 | KSR2 | 1.54817885 |
| 27 | PAK4 | 1.54278478 |
| 28 | LATS2 | 1.52419100 |
| 29 | TESK1 | 1.49617788 |
| 30 | NTRK1 | 1.37543370 |
| 31 | FGFR1 | 1.35929814 |
| 32 | BCKDK | 1.33143789 |
| 33 | CDK12 | 1.25220619 |
| 34 | SMG1 | 1.24986384 |
| 35 | CDK8 | 1.23540244 |
| 36 | MAPK11 | 1.12744578 |
| 37 | MAPKAPK3 | 1.10592798 |
| 38 | SIK2 | 1.10119956 |
| 39 | MAP2K6 | 1.08528459 |
| 40 | RET | 1.02272915 |
| 41 | RPS6KB2 | 1.01424232 |
| 42 | BRSK1 | 0.97469374 |
| 43 | PDK2 | 0.91752622 |
| 44 | BRAF | 0.91023060 |
| 45 | WNK1 | 0.88910730 |
| 46 | BMX | 0.88000887 |
| 47 | PDPK1 | 0.84801731 |
| 48 | PIM2 | 0.82882776 |
| 49 | MOS | 0.80675128 |
| 50 | NEK2 | 0.78866093 |
| 51 | WEE1 | 0.78612064 |
| 52 | TYRO3 | 0.77848552 |
| 53 | MAP3K13 | 0.76968054 |
| 54 | RAF1 | 0.76190355 |
| 55 | PBK | 0.72711795 |
| 56 | MAP3K6 | 0.71611401 |
| 57 | SCYL2 | 0.68334426 |
| 58 | STK39 | 0.67822405 |
| 59 | MTOR | 0.67320638 |
| 60 | EPHB1 | 0.67214641 |
| 61 | CDK7 | 0.66716847 |
| 62 | MAPKAPK5 | 0.66586663 |
| 63 | STK38 | 0.64094289 |
| 64 | PTK6 | 0.63474262 |
| 65 | TESK2 | 0.62777684 |
| 66 | DDR2 | 0.61281133 |
| 67 | LATS1 | 0.60065658 |
| 68 | CDK6 | 0.59807602 |
| 69 | ERBB4 | 0.55671984 |
| 70 | MAP3K1 | 0.52837015 |
| 71 | CDK15 | 0.51693135 |
| 72 | NME1 | 0.51442272 |
| 73 | SGK223 | 0.49008852 |
| 74 | SGK494 | 0.49008852 |
| 75 | CDK18 | 0.48532444 |
| 76 | LIMK1 | 0.47022441 |
| 77 | CDK11A | 0.46946864 |
| 78 | MAP3K8 | 0.46736542 |
| 79 | NEK6 | 0.46642220 |
| 80 | FER | 0.46415005 |
| 81 | FGFR2 | 0.45868044 |
| 82 | AKT2 | 0.44018555 |
| 83 | EPHB2 | 0.43468020 |
| 84 | DAPK1 | 0.42177539 |
| 85 | BUB1 | 0.41210224 |
| 86 | ABL2 | 0.39117055 |
| 87 | CDK14 | 0.38360998 |
| 88 | STK24 | 0.37074759 |
| 89 | PAK2 | 0.36690131 |
| 90 | NTRK3 | 0.33982287 |
| 91 | PDK1 | 0.33621950 |
| 92 | KSR1 | 0.33531838 |
| 93 | ILK | 0.33230146 |
| 94 | PRKG2 | 0.31232351 |
| 95 | PAK1 | 0.31187921 |
| 96 | PRKD3 | 0.30067237 |
| 97 | SRC | 0.28712927 |
| 98 | DYRK1B | 0.28658146 |
| 99 | MAPKAPK2 | 0.28346448 |
| 100 | CDK9 | 0.28176909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.30680173 |
| 2 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.85107518 |
| 3 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.97894206 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 2.77171041 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72088996 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.65709234 |
| 7 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.63110763 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46127492 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.42555940 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.22048635 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.15723384 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15532846 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.12073993 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.03339882 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95363705 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86391804 |
| 17 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.85002614 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.80961301 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.74528717 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69760852 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.62963306 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60580576 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60081836 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.51560337 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47496092 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46484457 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40721046 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40550156 |
| 29 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.36624181 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.32251343 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30538382 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26423395 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25540195 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.22784784 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19170483 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15138506 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14809556 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04142746 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.99277747 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98335142 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92103518 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92091030 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91800280 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90399043 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 0.86562306 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84269319 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78834359 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76895536 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74218540 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.73559780 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73259352 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72021493 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71217868 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70312586 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70305049 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.68200604 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67651967 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65958056 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65339761 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63597629 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61749140 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61097421 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60230324 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60204777 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.60095528 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59083216 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57582630 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55792373 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55036880 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54099466 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52740406 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51792707 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51628523 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50248541 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47896757 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47657397 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45906616 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44888340 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44779917 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41103682 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40266341 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39097735 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38224261 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37650729 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34101811 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.33592450 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.31621726 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.31021502 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30457827 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29964095 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29807592 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29581969 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29579038 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.28034568 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.24485182 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22612649 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15429524 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15059987 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.14622858 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.14019838 |

